← Product Code [PEK](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/PEK) · K132191 # SP-FIX SPINOUS PROCESS FIXATION PLATE (K132191) _Globus Medical, Inc. · PEK · Nov 22, 2013 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/PEK/K132191 ## Device Facts - **Applicant:** Globus Medical, Inc. - **Product Code:** [PEK](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/PEK.md) - **Decision Date:** Nov 22, 2013 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 888.3050 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The SP-Fix® Spinous Process Fixation Plate is a posterior non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1-S1), It is intended for plate fixation/attachment to the spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, trauma (i.e., fracture or dislocation), and/or tumor. The SP-Fix® spinous process fixation plate is intended for use with bone graft material and is not intended for stand-alone use. ## Device Story SP-Fix® Spinous Process Fixation Plate is a posterior non-pedicle supplemental fixation system; components include plates, rods, and barrels. Used by surgeons in clinical settings to stabilize spinal segments during fusion procedures. Device attaches to spinous processes to provide supplemental support; requires concurrent use of bone graft material. Not for stand-alone use. System provides mechanical stabilization to support fusion in patients with degenerative disc disease, spondylolisthesis, trauma, or tumor. Available in various sizes to accommodate patient anatomy. ## Clinical Evidence Bench testing only. Mechanical testing (static plate dissociation) conducted to demonstrate substantial equivalence. ## Technological Characteristics Constructed of titanium alloy (ASTM F136) and PEEK radiolucent polymer (ASTM F2026). System consists of plates, rods, and barrels for posterior spinal fixation. Non-active, mechanical implant. ## Regulatory Identification A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome. ## Predicate Devices - SP-Fix® Spinous Process Fixation Plate ([K102195](/device/K102195.md)) - Medtronic SPIRE® ([K032037](/device/K032037.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K132191 # 510(k) Summary: SP-Fix® Spinous Process Fixation Plate | Company: | Globus Medical Inc.
2560 General Armistead Ave.
Audubon, PA 19403
610-930-1800 | |-----------------|----------------------------------------------------------------------------------------------------------------------------------------------| | Contact: | Christina Kichula
Regulatory Affairs Group Manager | | Date Prepared: | July 12, 2013 | | Device Name: | SP-Fix® Spinous Process Fixation Plate | | Classification: | Per 21 CFR as follows:
§888.3050 Spinal Interlaminal Fixation Orthosis
Product Code: PEK
Regulatory Class: Class II, Panel Code 87. | | Predicate(s): | SP-Fix® Spinous Process Fixation Plate (K102195)
Medtronic SPIRE® (K032037) | #### Purpose: The purpose of this submission is to request clearance for additional SP-Fix® implants, including taller barrels and additional plate options. #### Device Description: The SP-Fix® Spinous Process Fixation Plate System consists of plates, rods, and barrels that are used to build a construct to provide supplemental stabilization of spinal segments to support fusion. The components are available in a range of sizes to fit the anatomical needs of a variety of patients. SP-Fix® implants are composed of titanium allov (per ASTM F136) and PEEK radiolucent polymer (per ASTM F2026). ### Indication for Use: The SP-Fix® Spinous Process Fixation Plate is a posterior non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1-S1), It is intended for plate fixation/attachment to the spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, trauma (i.e., fracture or dislocation), and/or tumor. The SP-Fix® spinous process fixation plate is intended for use with bone graft material and is not intended for stand-alone use. {1}------------------------------------------------ #### Technological Characteristics: The technological characteristics of the additional SP-Fix® implants are similar to the predicate devices in terms of design, dimensions, intended use, materials, and performance characteristics. #### Performance Data: Mechanical testing (static plate dissociation) was conducted and an engineering rationale was provided to demonstrate substantial equivalence to the predicate system. #### Basis of Substantial Equivalence: The additional SP-Fix® implants have been demonstrated to be substantially equivalent to predicate systems with respect to technical characteristics, performance, and intended use. The information provided within this premarket notification supports substantial equivalence to the predicate devices. Additional SP-Fix® implants perform as well as or better than the predicate device. {2}------------------------------------------------ #### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS) of the United States. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol, which is the HHS symbol, consisting of three abstract shapes that resemble human figures or birds in flight. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 November 22, 2013 Globus Medical, Incorporated Ms. Christina Kichula Regulatory Affairs Group Manager 2560 General Armistead Avenue Audubon, Pennsylvania 19403 Re: K132191 Trade/Device Name: SP-Fix® Spinous Process Fixation Plate Regulation Number: 21 CFR 888.3050 Regulation Name: Spinal interlaminal fixation orthosis Regulatory Class: Class II Product Code: PEK Dated: September 30, 2013 Received: October 1, 2013 Dear Ms. Kichula: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28. 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set {3}------------------------------------------------ #### Page 2 - Ms. Christina Kichula forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. Mark New elkerson -S Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ### 1. 2. 2. 1. ## Indications for Use Statement 510(k) Number: K132191 SP-Fix® Spinous Process Fixation Plate Device Name: ### INDICATIONS: The SP-Fix® Spinous Process Fixation Plate is a posterior non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1-S1). It is intended for plate fixation/attachment to the spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, trauma (i.e., fracture or dislocation), and/or tumor. The SP-Fix Spinous Process Fixation Plate is intended for use with bone graft material and is not intended for stand-alone use. OR Prescription Use _ × (Per 21 CFR §801.109) Over-The- Over-The-Counter Use_ (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) # RonaldiPAJean -S (Division Sign-Off) Division Of Orthopedic Devices 510 (k) Number: K132191 --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/PEK/K132191](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/PEK/K132191) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com